siRNA, Anti-SLC17A1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21275WQ-2OMe)

The product SIRGT21275WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC17A1 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC17A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_005074.3
Alternative Names NAPI-1; NPT-1; NPT1
Related Diseases Gout and Hyperuricemia
Purification HPLC
Target Gene
Gene ID 6568
Uniprot ID Q14916
Sub Cat Target Species Modification Scale  
SIRGT22275WQ-2F SLC17A1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23275WQ-2MOE SLC17A1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24275WQ-LNA SLC17A1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21275WQ-RB SLC17A1 Human Ribo-modified Inquiry
SIRGT22275WQ-BB SLC17A1 Human Backbone-modified Inquiry

Related Products